rcca-header
Clinical Trials

Phase 3, open-label trial of lenalidomide and low-dose dexamethasone with or without pembrolizumab (MK-3475) in newly diagnosed, treatment-naïve multiple myeloma who are ineligible for autologous stem cell transplant

Type of Cancer
Multiple Myeloma
Phase
Division (Location)
East Brunswick, NJ, Freehold, NJ, Howell, NJ, Little Silver, NJ, Mount Holly, NJ, Sparta, NJ
Study ID
NCT#
Brief Description
Phase 3, open-label trial of lenalidomide and low-dose dexamethasone with or without pembrolizumab (MK-3475) in newly diagnosed, treatment-naïve multiple myeloma who are ineligible for autologous stem cell transplant

To find out more about this clinical trial, or to schedule an appointment, call (201) 518-3587.